Journal of Controlled Release · 2022 · 40 citations · 37 references
PharmacyMolecular BiologyOncologyCell SignalingMolecular OncologyNanotechnologyCancer BiomarkersCancer NanomedicineNanomedicineProtein DeliveryTargeted Cancer TherapyTheranostic NanoparticlesActive Tumor TargetingCancer NanotherapyEgfr DependenceEgfr InhibitionEpidermal Growth Factor Receptor Targeting LigandsNanoparticle PharmacologyTumor Targeting Ligands
37
Identification and characterization of a new member of the TNF family that induces apoptosis
Steven R. Wiley, Ken Schooley, Pamela J. Smolak et al. · Immunity · 1995 · 2.9K citations · Full text
Safety and antitumor activity of recombinant soluble Apo2 ligand
Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
X-linked IAP is a direct inhibitor of cell-death proteases
Quinn L. Deveraux, Ryōsuke Takahashi, Guy S. Salvesen et al. · Nature · 1997 · 1.9K citations · Full text